icon-circle-smiley-face

News Links

Daily Care News for March 14, 2023

Insulin edema, a little known entity Comparison of regular with NPH insulin vs. premix insulin in children and adolescents with type 1 diabetes in a resources-limited setting: a retrospective data analysis Psychological consequences of the COVID-19 pandemic in people with type 1 diabetes: A systematic literature review Ramadan fasting and type 1 diabetes: a scoping review protocol Early Gastrointestinal Neuropathy Assessed by Wireless Motility Capsules in Adolescents with Type 1 Diabetes (Full text HTML, PDF) Protein intake and postprandial hyperglycemia in children and adolescents with type 1 diabetes mellitus, a pilot study Efficacy of unblinded and blinded intermittently scanned continuous […]

Read More

Celiac News for February 15, 2023

Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need Gary Gray, who co-discovered possible celiac disease treatment, dies at 89 The Influence of SARS-CoV-2 Pandemic on the Diagnosis of Celiac Disease and Clinical Practice in Pediatric Gastroenterology (Full text HTML, PDF) Association of Serum Albumin, Globulin, and Transferrin Levels in Children of Poorly Managed Celiac Disease Patterns of practice in the diagnosis, dietary counselling and follow-up of patients with celiac disease- A patient-based survey Subclinical Celiac Disease Unmasked by Immune Checkpoint Inhibitor Therapy Obsessive-Compulsive Symptomatology and Disgust Propensity in Disordered […]

Read More

Press Releases and Product Information February 15, 2023

Medicare to cover Dexcom G7 when it launches this week Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies DARIO PARTNERS TO INTEGRATE DEXCOM CGM DATA Utah-based nonprofit set to open $140M insulin plant in Petersburg Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes Provention Bio: Ability To Expand T1D Market Presence With Second Half 2023 Data Lilly and IABL Collaborate to Ensure Patient Access to High-Quality Affordable Insulin in Bangladesh

Read More

Popular Press News for February 15, 2023

Chiefs’ Super Bowl TE has Type 1 diabetes. Here are the kids he’s inspired The high cost of diabetes drugs has led to a flourishing black market ‘I’m pretty experienced’: Decatur 13-year-old talks about growing up with type 1 diabetes Medicare caps insulin costs at $35 a month. Can Biden get that price for all Americans? Overweight and Obesity in People With Type 1 Diabetes Nearly Same as General Population North Carolina teen among first in U.S. to receive new diabetes drug at Children’s Hospital of Richmond at VCU How a new treatment for diabetes offers hope for millions Be […]

Read More

Social Media Links for February 15, 2023

Spare a Rose – by and for the community If You’ve Lived with T1D for 10, 25, 50, or 75 Years… Cannabis Side-Effects Can Mimic DKA in People with Type 1 Diabetes Biden Calls for $35 Monthly Insulin Price Cap for All Americans Join Effort to Better Understand Mental Health and Diabetes Should You Call Someone ‘Diabetic’? 7 Ways to Get Better Sleep With an Insulin Pump Dexcom G7 Available in US Starting Feb. 17 Sex and Diabetes FDA Approves New Implantable Device to Treat Pain From Diabetic Nerve Damage All About the Bigfoot Unity, a Smart Dosing System for […]

Read More

Research News for February 15, 2023

Can Lab-Grown Beta Cells Revolutionize Diabetes Care? Diabetes breakthrough brings world closer to life without insulin Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines (Full text HTML, PDF) Effect of Epstein-Barr Virus Infection on Selected Immunological Parameters in Children with Type 1 Diabetes Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability (Full text HTML, PDF) DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development Neutrophil extracellular trap: A key player in the […]

Read More

Daily Care News for February 15, 2023

Extended use of an open-source automated insulin delivery system in children and adults with type 1 diabetes: The 24-week continuation phase following the CREATE randomized controlled trial. Glucagon use declines from 2011 to 2021 among adults with diabetes Type 1 Diabetes: Researchers Urge More Guidance on Diet, Exercise Type 1 Diabetes No Longer a Disease of the Thin, Advice Needed Family-centered Interventions Improve Health Outcomes in Children, Adolescents With T1D Flexible patient-reported outcome-based telehealth follow-up for type 1 diabetes: A qualitative study One year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes […]

Read More

Legislative and Policy News for February 8, 2023

Bill caps North Dakota insulin cost at $25 per month Josh Hawley (R-Mo.) renews D.C. push to cap insulin costs

Read More

Celiac News for February 8, 2023

Celiac Disease Could Raise Heart Risks, Study Finds Tips for Living Sustainably With Celiac Disease How do I tell my hosts I have celiac disease and can’t eat gluten? IgE-Mediated Food Allergy: Increased Occurrence of Celiac Disease The Connection Between Anti-Tissue Transglutaminase Antibodies and Intestinal Mucosal Damage in Children with Celiac Disease EARLY ANTIBODY DYNAMICS IN A PROSPECTIVE COHORT OF CHILDREN AT-RISK FOR CELIAC DISEASE Intussusception as Rare Presenting Sign of Pediatric Celiac Disease: A Case Series Gluten-free diet adherence in children with screening-detected celiac disease using a prospective birth cohort study (Full text HTML, PDF) Analytical and functional approaches […]

Read More

Press Releases and Product Information February 8, 2023

Abbott device approval sets up battle with Medtronic, Nevro for diabetic peripheral neuropathy treatment

Read More